Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.
Ophthalmol Sci. 2024 Feb 13;4(4):100492. doi: 10.1016/j.xops.2024.100492. eCollection 2024 Jul-Aug.
Ophthalmol Sci. 2024.
PMID: 38682029
Free PMC article.
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial.
Dohlman TH, McSoley M, Amparo F, Carreno-Galeano T, Wang M, Dastjerdi M, Singh RB, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Gomes JAP, Perez VL, Yin J, Dana R.
Dohlman TH, et al. Among authors: carreno galeano t.
Ophthalmology. 2022 Aug;129(8):865-879. doi: 10.1016/j.ophtha.2022.03.024. Epub 2022 Mar 28.
Ophthalmology. 2022.
PMID: 35358592
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite